ZEN-3694 (BET-IN-19): Mechanism of Action

ZEN-3694 (BET-IN-19) MOA:Targeting BET/Androgen Receptor Pathway for Metastatic Castration-Resistant Prostate Cancer

🎯 check ZEN-3694 (BET-IN-19) product page

ZEN-3694 (BET-IN-19) is a potent and selective BET bromodomain inhibitor. It affects AR and MYC signaling, by blocking the interaction between BET proteins and acetylated histones, inhibiting oncogene transcription and tumor cell proliferation.

Primary Applications and Mechanism of Action